TVTX EPS Estimates
Travere Therapeutics, Inc.
$49.60
+$0.73(+1.49%)
41
Overall
40
Value
20
Tech
63
Quality
Market Cap
$4.76B
Volume
1.01M
52W Range
$22.59 - $68.73
Target Price
$75.21
TVTX EPS estimates: the consensus estimate for Travere Therapeutics, Inc.'s current fiscal year is -$0.92 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TVTX EPS Estimates
- EPS estimate, current quarter
- $-0.25
- EPS estimate, next quarter
- $0.27
- EPS estimate, current year
- $-0.92
- EPS estimate, next year
- $2.49
- EPS growth, 3-year
- +59.51%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.29 |
| 2024 | $-4.08 |
| 2023 | $-1.50 |
| 2022 | $-4.37 |
| 2021 | $-3.01 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TVTX | $49.60 | +1.5% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Travere Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW